OR10AG1 Inhibitors
OR10AG1 inhibitors encompass a range of compounds that affect the olfactory signaling pathways and processes in which the OR10AG1 protein is involved. This group includes sodium channel blockers, calcium channel blockers, and other agents that interfere with ion homeostasis and neuronal excitability. For instance, quinidine and lidocaine are known to reduce the activity of voltage-gated sodium channels, which are crucial for the initiation and propagation of action potentials in olfactory receptor neurons. These action potentials are necessary for the proper functioning of OR10AG1, as they lead to the events that ultimately result in olfactory perception. By inhibiting these sodium channels, these compounds can decrease the likelihood of action potential occurrence, thereby reducing the activity of OR10AG1.
On the other hand, compounds like ruthenium red, BAPTA, and thapsigargin target calcium-dependent processes. Calcium plays a pivotal role in intracellular signaling cascades that are activated upon ligand binding to olfactory receptors like OR10AG1. The binding of an odorant molecule to OR10AG1 usually triggers a G-protein-coupled response that results in increased intracellular calcium, leading to a series of events that culminate in neuronal firing and signal transmission. By chelating calcium or inhibiting calcium channels, these compounds can disrupt the signaling cascadeessential for OR10AG1 to convey olfactory information.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Quinidine | 56-54-2 | sc-212614 | 10 g | $104.00 | 3 | |
A sodium channel blocker that inhibits voltage-gated sodium channels. OR10AG1 is associated with olfactory signal transduction, which involves sodium ion influx. Quinidine's blockade of these channels can reduce the depolarization necessary for signal propagation, indirectly inhibiting OR10AG1 activity. | ||||||
Lidocaine | 137-58-6 | sc-204056 sc-204056A | 50 mg 1 g | $51.00 $131.00 | ||
A local anesthetic and sodium channel blocker. Lidocaine's inhibition of sodium channels can decrease neuronal excitability. As OR10AG1 function relies on neuronal firing for olfactory perception, this reduction in excitability can indirectly inhibit OR10AG1 activity. | ||||||
Amiloride • HCl | 2016-88-8 | sc-3578 sc-3578A | 25 mg 100 mg | $22.00 $57.00 | 6 | |
A diuretic that blocks epithelial sodium channels. Amiloride's inhibition of sodium channels—including those involved in olfactory epithelium—can impair ion flux, thus indirectly lessening OR10AG1-mediated olfactory signaling. | ||||||
Capsazepine | 138977-28-3 | sc-201098 sc-201098A | 5 mg 25 mg | $148.00 $459.00 | 11 | |
A TRPV1 antagonist that can affect thermosensation and pain perception. By modulating TRPV1, which is implicated in the regulation of ion channel activity, capsazepine can influence the neuronal excitability of olfactory sensory neurons, thereby indirectly inhibiting OR10AG1. | ||||||
Ruthenium red | 11103-72-3 | sc-202328 sc-202328A | 500 mg 1 g | $188.00 $250.00 | 13 | |
An inhibitor of various ion channels, including calcium channels. OR10AG1 signaling involves calcium-mediated processes; thus, ruthenium red's inhibition of calcium influx can indirectly inhibit OR10AG1 activity. | ||||||
BAPTA, Free Acid | 85233-19-8 | sc-201508 sc-201508A | 100 mg 500 mg | $68.00 $267.00 | 10 | |
A calcium chelator that buffers intracellular calcium levels. By sequestering calcium, BAPTA can prevent the intracellular signaling required for OR10AG1 activity, indirectly leading to its inhibition. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
An inhibitor of the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA). By disrupting calcium homeostasis, thapsigargin can affect the intracellular signaling pathways that OR10AG1 relies upon, indirectly inhibiting its function. | ||||||
Lanthanum | 7439-91-0 | sc-250228 | 25 g | $180.00 | ||
A lanthanum(III) ion that blocks calcium channels. By inhibiting calcium channels, La3+ can diminish calcium signaling in olfactory neurons, thereby indirectly inhibiting OR10AG1 activity. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
By blocking calcium channels, verapamil can attenuate the calcium-dependent processes of olfactory transduction, thus indirectly inhibiting OR10AG1. | ||||||
Diltiazem | 42399-41-7 | sc-204726 sc-204726A | 1 g 5 g | $209.00 $464.00 | 4 | |
A benzothiazepine that blocks L-type calcium channels. Diltiazem's inhibition of these channels can reduce calcium influx necessary for olfactory signal transduction, indirectly inhibiting OR10AG1. | ||||||